New Delhi, December 06, 2004 -- Oracle India Private Limited, a wholly owned subsidiary of Oracle Corporation, the world's largest enterprise software company, today announced that Asian Clinical Trials Pvt. Ltd (ACT), a contract/clinical research organization has successfully implemented Oracle Clinical.

Oracle clinical has enabled ACT, a leading player in the emerging market of Clinical Data Management (CDM), to conform to FDA regulations and validations while handling critical clinical data. Further, Oracle Clinical has helped with integration of databases, faster creation of case report forms and, more importantly, quicker time-to-market for their clients.

Oracle Clinical is a powerful, comprehensive clinical data management solution which allows companies to standardize and control data definitions and data usage across a global operation, ensuring that data is defined, managed, and interpreted consistently worldwide. This expedites the multinational regulatory approval process and reduces cycle times in critical clinical trial processes, thereby accelerating time to market for new products.

"It is a well-established benchmark in the global pharmaceutical industry that every day gained in accelerating a product to market may be worth $1-3 million in additional sales revenue. Oracle Clinical has helped us streamline this critical and costly process," said Mr. Venkatraman Sunder, vice president - Corporate Affairs, Asian Clinical Trials.

"Oracle Clinical has helped us improve our efficiencies and provide our clients with a sense of security while we handle their critical data," he added.

"Oracle Clinical will help ACT enhance their productivity levels and support them to serve their clients better. It is designed to be a robust, high-performance application that can handle thousands of studies and hundreds of gigabytes of data", said Subhomoy Sengupta, general manager - Sales, Oracle India.

About ACT
Asian Clinical Trials Pvt. Ltd. (ACT) is a Contract/ Clinical Research Organization incorporated in April 2001 by Mr. Venkat Jasti, Managing Director of Suven Life Sciences Limited and CEO of Synthon Chiragenics, New Jersey a unit of Suven Life Sciences USA LLC. Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. In 2003 ACT acquired assets of Synthon Chiragenics Corporation.

ACT is composed of highly experienced professionals in the field of clinical trials. ACT designs and conducts for both small and large national and multinational pharmaceutical, biotechnology, and medical device company, clinical phase II to IV trials without compromising on ICH-GCP standards.

About Oracle India
Oracle India Private Ltd. a wholly owned subsidiary of Oracle Corporation, the world's largest enterprise software company, has been operating in India for more than a decade. Oracle was one of the first international software companies to set up an India Development Centre in 1994. Today, Oracle's two India Development Centers, at Bangalore and Hyderabad, work closely with Oracle's global software development team, headquartered at Redwood Shores, California, on the entire Oracle product family. India is also a hub for several of Oracle's global support, consulting and financial services operations. Through its offices in Delhi, Bangalore, Kolkata, Chennai, Hyderabad, Mumbai, and Gurgaon, and an extensive network of more than 200 channel and alliance partners under the Oracle PartnerNetwork, Oracle India markets the complete range of Oracle products and services across India. Oracle database is supported on 13 major In dian languages. Oracle India has more than 6,250 customers in the telecommunications, banking, insurance, manufacturing and utilities industries, in both the government and private sectors.

About Oracle
Oracle is the world's largest enterprise software company. For more information about Oracle visit our website at www.oracle.com

Trademark
Oracle is a registered trademark of Oracle Corporation and/or its affiliates. All other names and trademarks are the property of their respective owners